These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
829 related articles for article (PubMed ID: 11082299)
1. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO. Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299 [TBL] [Abstract][Full Text] [Related]
2. Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts. Kremmer T; Pälyi I; Daubner D; Boldizsár M; Vincze B; Paulik E; Sugár J; Pokorny E; Túry E Anticancer Res; 1991; 11(5):1807-13. PubMed ID: 1768053 [TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effect of spermine depletion by N-cyclohexyl-1,3-diaminopropane in human breast cancer cells. Huber M; Poulin R Cancer Res; 1995 Feb; 55(4):934-43. PubMed ID: 7850811 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response. Singh AB; Thomas TJ; Thomas T; Singh M; Mann RA Cancer Res; 1992 Apr; 52(7):1840-7. PubMed ID: 1551114 [TBL] [Abstract][Full Text] [Related]
5. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion. Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054 [TBL] [Abstract][Full Text] [Related]
6. The potential of a novel polyamine transport inhibitor in cancer chemotherapy. Aziz SM; Gillespie MN; Crooks PA; Tofiq SF; Tsuboi CP; Olson JW; Gosland MP J Pharmacol Exp Ther; 1996 Jul; 278(1):185-92. PubMed ID: 8764350 [TBL] [Abstract][Full Text] [Related]
7. Synergistic inhibition of polyamine synthesis and growth by difluoromethylornithine plus methylthioadenosine in methylthioadenosine phosphorylase-deficient murine lymphoma cells. Yamanaka H; Kubota M; Carson DA Cancer Res; 1987 Apr; 47(7):1771-4. PubMed ID: 3102048 [TBL] [Abstract][Full Text] [Related]
9. Suramin selectively inhibits carcinoma cell growth that is dependent on extracellular polyamines. Sandgren S; Belting M Anticancer Res; 2003; 23(2B):1223-8. PubMed ID: 12820375 [TBL] [Abstract][Full Text] [Related]
10. Differential effect of alpha-difluoromethylornithine on the in vivo uptake of 14C-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumor. Heston WD; Kadmon D; Covey DF; Fair WR Cancer Res; 1984 Mar; 44(3):1034-40. PubMed ID: 6420052 [TBL] [Abstract][Full Text] [Related]
11. The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo. Levêque J; Burtin F; Catros-Quemener V; Havouis R; Moulinoux JP Anticancer Res; 1998; 18(4A):2663-8. PubMed ID: 9703925 [TBL] [Abstract][Full Text] [Related]
12. Isolation of a polyamine transport deficient cell line from the human non-small cell lung carcinoma line NCI H157. Shao D; Xiao L; Ha HC; Casero RA J Cell Physiol; 1996 Jan; 166(1):43-8. PubMed ID: 8557774 [TBL] [Abstract][Full Text] [Related]
13. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity. Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541 [TBL] [Abstract][Full Text] [Related]
14. Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. Porter CW; Ganis B; Libby PR; Bergeron RJ Cancer Res; 1991 Jul; 51(14):3715-20. PubMed ID: 2065327 [TBL] [Abstract][Full Text] [Related]
15. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo. Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane. Igarashi K; Koga K; He Y; Shimogori T; Ekimoto H; Kashiwagi K; Shirahata A Cancer Res; 1995 Jun; 55(12):2615-9. PubMed ID: 7780977 [TBL] [Abstract][Full Text] [Related]
17. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells. Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A Breast Cancer Res Treat; 2007 Sep; 105(1):29-36. PubMed ID: 17143592 [TBL] [Abstract][Full Text] [Related]
19. Regulation of the Na(+)-dependent and the Na(+)-independent polyamine transporters in renal epithelial cells (LLC-PK1). Parys JB; De Smedt H; Van Den Bosch L; Geuns J; Borghgraef R J Cell Physiol; 1990 Sep; 144(3):365-75. PubMed ID: 2118145 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action. Porter CW; Bernacki RJ; Miller J; Bergeron RJ Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]